| Literature DB >> 36097560 |
Faith Miaomiao Zheng1, Iliana Gehui Yan1, Duangporn Duangthip1, Sherry Shiqian Gao1,2, Edward Chin Man Lo1, Chun Hung Chu1.
Abstract
Silver diamine fluoride (SDF) was developed in Japan in the 1960s. It is used to control early childhood caries, arrest root caries, prevent fissure caries and secondary caries, desensitise hypersensitive teeth, remineralise hypomineralised teeth, prevent dental erosion, detect carious tissue during excavation and manage infected root canals. SDF is commonly available as a 38% solution containing 255,000 ppm silver and 44,800 ppm fluoride ions. Silver is an antimicrobial and inhibits cariogenic biofilm. Fluoride promotes remineralisation and inhibits the demineralisation of teeth. SDF also inactivates proteolytic peptidases and inhibits dentine collagen degradation. It arrests caries without affecting dental pulp or causing dental fluorosis. Indirect pulp capping with SDF causes no or mild inflammatory pulpal response. However, direct application of SDF to dental pulp causes pulp necrosis. Furthermore, SDF stains carious lesions black. Patients must be well informed before SDF treatment. SDF therapy is simple, painless, non-invasive, inexpensive, and requires a simple armamentarium and minimal support. Both clinicians and patients generally accept it well. In 2021, the World Health Organization included SDF as an essential medicine that is effective and safe for patients. Moreover, it can be used for caries control during the COVID-19 pandemic because it is non-aerosol-generating and has a low risk of cross-infection.Entities:
Keywords: Caries; Dentine; Hypersensitivity; Prevention; Silver diamine fluoride
Year: 2022 PMID: 36097560 PMCID: PMC9463534 DOI: 10.1016/j.jdsr.2022.08.001
Source DB: PubMed Journal: Jpn Dent Sci Rev ISSN: 1882-7616
Countries and guidelines for silver diamine fluoride (SDF) use (adapted from Gao et al., 2021 [1]).
| Countries | Guidelines for SDF use (Reference number) |
|---|---|
| Egypt | No |
| Ghana | No |
| Kenya | No |
| Nigeria | No |
| South Africa | No |
| India | No |
| Japan | Clinical practice guideline for caries treatment |
| Mongolia | Standard guidance and recommendation for SDF |
| Thailand | Guideline on caries diagnosis and management |
| Finland | National guidelines for caries management |
| Switzerland | Clinical guidance and recommendation for caries management |
| United Kingdom | Standard operating procedure (England) New SDF resources by the British Society of Paediatric Dentistry |
| Canada | New guidance in treating caries by the Canadian Dental Association |
| United States | Guidelines for SDF use by the American Academy of Pediatric Dentistry Evidence-based clinical practice guideline on nonrestorative treatments for carious lesions by the American Dental Association |
| Argentina | No |
| Brazil | National protocol in primary health care for the Brazilian public health system Guidelines for clinical procedures in paediatric dentistry |
| Australia | Australian fluoride guidelines |
Concentrations of some commercially available SDF solutions for dental use.
| SDF% | Product | Manufacturer | Country |
|---|---|---|---|
| 38% | Advantage Arrest | Elevate Oral Care | US |
| 38% | Bioride | DENTSPLY Industrial & Commercial Ltd. | Brazil |
| 38% | e-SDF | Kids-e-Dental | India |
| 38% | Dengen Caries Arrest | Dengen Dental | India |
| 38% | Fagamin | Tedequim SRL | Argentina |
| 38% | Fluoroplat | NAF Laboratory | Argentina |
| 38% | Riva Star | SDI Dental Ltd. | Australia |
| 38% | Saforide | Toyo Seiyaku Kasei Co. Ltd. | Japan |
| 38% | Topamine | Dentalife Australia Pty. Ltd. | Thailand |
| 30% | Ancárie | Maquira, Maringá | Brazil |
| 30% | Cariestop | Biodinamica | Brazil |
| 12% | Ancárie | Maquira, Maringá | Brazil |
| 12% | Cariestop | Biodinamica | Brazil |
| 10% | Cariestatic | Inodon Dentistry | Brazil |
| 3.8% | Saforide RC | Toyo Seiyaku Kasei Co. Ltd. | Japan |
For root canal therapy